Related Experiment Video
Updated: Jul 10, 2026
Proteomics to Identify Proteins Interacting with P2X2 Ligand-Gated Cation Channels
Published on: May 18, 2009
Molecular Hybridization of Clinically Relevant P2X7 Antagonists
Nicholas B Lynch1, Charleigh T A Agius2, André D J McKenzie1
1School of Chemistry, Faculty of Science, The University of Sydney, Sydney, New South Wales, Australia.
None:
The P2X7 receptor plays a pivotal role in the development of neurodegenerative disease states, yet no therapies targeting this receptor have reached the market to date. This work utilized a hybridization approach to combine clinically relevant antagonists AZD-9056 and JNJ-54175446 to discover new P2X7 antagonists. Here, we report the synthesis and in vitro and in silico evaluation of a library of 22 compounds to explore new chemical space around these clinically validated molecules. This study emphasizes the value of molecular hybridization in drug discovery and provides the basis for future P2X7 receptor antagonist development.
Related Concept Videos
01:25Drug-Receptor Interaction: Agonist
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
01:29Drug-Receptor Interactions
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.